NUS NU SKIN ENTERPRISES, INC.
Updated
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
NU SKIN ENTERPRISES, INC. (NUS) is a industrials company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $228 million. Shares last traded at $4.68, 67.8% below their 52-week high. Over the past year the stock is down 61.2%. Net profit margin is -15.7%, below the peer median of 0.7%. Revenue declined 14.3% year over year. The shares yield 29.6% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
NUS Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $12M | $0.24 | 7% |
| 2024-12-31 | $12M | $0.24 | — |
| 2023-12-31 | $78M | $1.56 | 903% |
| 2022-12-31 | $77M | $1.52 | 74% |
| 2021-12-31 | $76M | $1.48 | 52% |
| 2020-12-31 | $78M | $1.49 | 41% |
| 2019-12-31 | $82M | $1.47 | 47% |
| 2018-12-31 | $81M | $1.43 | 66% |
| 2017-12-31 | $76M | $1.39 | 59% |
| 2016-12-31 | $78M | $1.40 | 55% |
| 2015-12-31 | $81M | $1.37 | 61% |
| 2014-12-31 | $81M | $1.34 | 43% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $-5.12 | 2026-08-10 |
| Q1 2026 | $0.04 | 2026-05-08 |
| FY 2025 | $3.18 | 2026-02-13 |
| Q3 2025 | $2.91 | 2025-11-07 |
| Q2 2026 | $2.59 | 2026-08-10 |
| Q1 2026 | $2.14 | 2026-05-08 |
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
NUS vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Updated
| MCK | McKesson Corporation | $107.4B | 23.39 | 0.26 | 1.1% | -0.40% |
| COR | Cencora | $64.3B | 24.51 | 0.19 | 0.8% | +0.23% |
| CAH | Cardinal Health | $57.8B | 34.78 | 0.24 | 0.7% | +1.24% |
| HLF | Herbalife Ltd. | $1.3B | 7.76 | 0.25 | 3.2% | -0.08% |
| NUS | NU SKIN ENTERPRISES, INC. | $228M | -1.05 | 0.17 | -15.7% | -2.90% |
| COSM | Cosmos Health Inc. | $27M | -1.10 | 0.37 | -33.1% | +18.78% |
| HWH | HWH International Inc. | $15M | -5.54 | — | — | +2.98% |
| MEDS | DataMeds AI, Inc. | $3M | -0.03 | — | — | -4.49% |
| HKPD | Cellyan Biotechnology Co., Ltd | — | — | — | — | -7.89% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.